Factors mediating cancer risk in systemic lupus erythematosus. (October 2022)

• Record Type: Journal Article
• Authors: Hardenbergh, Dylan; Molina, Emily; Naik, Rakhi; Geetha, Duvuru; Chaturvedi, Shruti; Timlin, Homa
• Is Part Of: Lupus. Volume 31:Number 11(2022)
• Page Start: 1285
• Page End: 1295
• Publication Date: 2022-10
• Subjects: Systemic lupus erythematosus -- Periodicals; 616.772005
• DOI: 10.1177/09612033221122163
• Languages: English
• ISSNs: 0961-2033

Abstract

Patients with systemic lupus erythematosus (SLE) are at an elevated risk for certain cancers compared to the population at large. Cancers seen at higher rates in the SLE population include hematologic malignancies, such as non-Hodgkin lymphoma, and cancers of the lung and thyroid. SLE patients also have a decreased risk for certain malignancies, such as breast cancer, melanoma, and prostate cancer. We review the literature on risk factors for malignancy in patients with SLE and discuss the exogenous and innate factors that are thought to contribute to the unique pattern of cancer risk observed in this patient population. These risk factors are important for providers of SLE patients to understand in order to maintain high clinical suspicion and detect malignancy as soon as possible. Further research is needed to determine the most effective guidelines on counseling patients on cancer screening and prevention.